Skip to main content
Veterinary Medicines

BUR-706 lyofilizát na suspenziu pre kurčatá

Authorised
  • Infectious bursal disease virus, strain S706, Live

Product identification

Medicine name:
BUR-706 lyofilizát na suspenziu pre kurčatá
Active substance:
  • Infectious bursal disease virus, strain S706, Live
Target species:
  • Chicken
Route of administration:
  • Ocular use
  • Nasal use
  • Nebulisation use
  • In drinking water use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain S706, Live
    4.00
    log10 cell culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Ocular use
    • Chicken
      • All relevant tissues
        0
        day
  • Nasal use
    • Chicken
      • All relevant tissues
        0
        day
  • Nebulisation use
    • Chicken
      • All relevant tissues
        0
        day
  • In drinking water use
    • Chicken
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • USKVBL
Authorisation number:
  • 97/205/94-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 21/12/2021
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."